Volpara: Coming into stronger quarters By Scott Power 19 November 2018, 12:30 PM VHT posted its 1HFY19 result which was broadly in line with expectations. Read more...
ResMed Inc: Expands long-term care SaaS portfolio By Derek Jellinek 08 November 2018, 11:38 AM We maintain our Add rating. Read more...
Volpara Health Technologies By Scott Power 29 October 2018, 2:22 PM Japan surprise and public screening win Read more...
ResMed Inc: 1Q beats – strong and balanced growth By Derek Jellinek 29 October 2018, 11:44 AM 1Q results were above expectations, driven by the fifth straight quarter of double digit sales growth, an expanding product range, stable gross margins and strength in the company's leading connected-care offerings. Read more...
Nanosonics: Share price fall creates opportunity By Scott Power 26 October 2018, 3:12 PM Given market volatility and the resultant share price fall we have moved our recommendation to Add. Read more...
Smiles Inclusive – Set for growth By Scott Power 27 August 2018, 8:46 AM SIL have hit their prospectus forecasts and delivered a solid maiden result Read more...
ResMed Inc – 4Q inline By Derek Jellinek 06 August 2018, 1:17 PM We continue to forecast improving operating leverage Read more...
ImpediMed – Waiting for the data By Scott Power 01 August 2018, 12:18 PM 4Q results show only modest revenue growth – published data is key Read more...
Ebos Group – A big fish landed By Scott Power 03 July 2018, 4:10 PM Ebos Group has a won a tender to act as the third party distributor to the Chemist Warehouse stores. This is a major contract for EBO and a major loss for the incumbent distributor is Sigma. Read more...
Video: Dr Ralph Highnam, Volpara Health Technologies (VHT) By Scott Power 02 July 2018, 9:39 AM At the latest Morgans Business Breakfast (20th June), Dr Ralph Highnam discussed the Volpara story and how they have grown to become a global leader in the battle against breast cancer. Read more...